Rankings
▼
Calendar
ZTS FY 2022 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$54B
FY 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$8.1B
+3.9% YoY
Gross Profit
$5.5B
67.8% margin
Operating Income
$2.9B
36.2% margin
Net Income
$2.1B
26.2% margin
EPS (Diluted)
$4.49
Cash Flow
Operating Cash Flow
$1.9B
Free Cash Flow
$1.3B
Stock-Based Comp.
$62M
Balance Sheet
Total Assets
$14.9B
Total Liabilities
$10.5B
Stockholders' Equity
$4.4B
Cash & Equivalents
$3.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8.1B
$7.8B
+3.9%
Gross Profit
$5.5B
$5.3B
+3.1%
Operating Income
$2.9B
$2.8B
+4.5%
Net Income
$2.1B
$2.0B
+3.8%
← Q4 2021
All Quarters
Q1 2022 →